Development of bullous pemphigoid during treatment of psoriasis with ustekinumab: a case report and literature review

Ustekinumab is a biological therapy that has been approved for treating moderate-to-severe psoriasis. Although injection site reactions, nasopharyngitis, headaches, and infections are the common adverse events associated with ustekinumab, the development of bullous pemphigoid (BP) is also thought to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Luyang, Huang, Dawei, Lu, Jiajing, Zhang, Yuexin, Li, Ying, Yi, Xuemei, Shi, Yuling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240285/
https://www.ncbi.nlm.nih.gov/pubmed/37283625
http://dx.doi.org/10.3389/fmed.2023.1171802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240285/
https://www.ncbi.nlm.nih.gov/pubmed/37283625
http://dx.doi.org/10.3389/fmed.2023.1171802

Ejemplares similares